Cheaper anti-cancer drug effective in treating most common cause of blindness in older adults
Two drug treatments Lucentis and Avastin are equally effective in treating neovascular or wet age-related macular degeneration
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
SC asks centre to discuss clinical trial regulation with state/ UT health authorities
PIL petitioners to submit suggestions in two weeks; ISCR expresses concerns on slowdown of trial approvals
The rise of the orphans
They might target small patient populations, but that hasn't deterred orphan drugs from making their impact felt. No wonder then…
’Piramal Enterprises’ diagnostic division business is expected to touch Rs…
M Neelam Kachhap speaks to Vijay Shah, Executive Director and COO, Piramal Enterprises to track the growth path
IPA to partner with state pharmacist associations
Associations from Karnataka, Kerala and Goa to be affiliated
UCB sues 15 companies over epilepsy drug Vimpat
According to IMS Health data for the 12 months ending March 31, 2013, Vimpat tablets and Solution had total US sales of…
Sun Pharma announces US FDA approval for generic Prandin tabs
Company has 180-day marketing exclusivity
Lupin receives FDA approval for generic Glumetza ER tabs
Is indicated as adjunct to diet and exercise to improve glycemic control in adults with type-2 diabetes mellitus
Cipla India completes accquisition of Cipla Medpro SA
The acquisition aims to strengthen Cipla’s commitment to South Africa and the broader African continent
Novartis, Biological E sign agreement to protect against typhoid and paratyphoid fevers
License agreement advances a Novartis goal to deliver accessible and affordable vaccines that address unmet medical need in…